Neural precursor cells cultured at physiologically relevant oxygen tensions have a survival advantage following transplantation

Stem Cells Translational Medicine

Volumn 2, Issue 6, 2013, Pages 462-472

  Stacpoole, Sybil R L ^a   Webber, Daniel J ^a   Bilican, Bilada ^b   Compston, Alastair ^a   Chandran, Siddharthan ^b   Franklin, Robin J M ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Cell transplantation; Hypoxia; Neural stem cell; Oligodendrocytes

Indexed keywords

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; BRAIN HYPOXIA; CELL CULTURE; CELL DEATH; CELL ISOLATION; CELL TRANSPLANTATION; CONTROLLED STUDY; HIPPOCAMPUS; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MICROSCOPY; NEURAL STEM CELL; NEWBORN; NONHUMAN; OLIGODENDROGLIA; OXYGEN TENSION; RAT; ANIMAL; BRAIN CORTEX; CELL DIFFERENTIATION; CELL SURVIVAL; CULTURE TECHNIQUE; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION; GENETICS; GRAFT SURVIVAL; HYPEROXIA; HYPOXIA; METABOLISM; METHODOLOGY; OLIGODENDROCYTES; OXIDATIVE STRESS; PATHOLOGY; PATHOPHYSIOLOGY; PRIMARY CELL CULTURE; SPRAGUE DAWLEY RAT; STEM CELL TRANSPLANTATION;

RATTUS;

BETA3 TUBULIN, RAT; BIOLOGICAL MARKER; INTERMEDIATE FILAMENT PROTEIN; NERVE PROTEIN; NESTIN; OXYGEN; TUBULIN;

CELL TRANSPLANTATION; HYPOXIA; NEURAL STEM CELL; OLIGODENDROCYTES;

ANIMALS; ANIMALS, NEWBORN; BIOLOGICAL MARKERS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL SURVIVAL; CEREBRAL CORTEX; GENE EXPRESSION; GRAFT SURVIVAL; HIPPOCAMPUS; HYPEROXIA; INTERMEDIATE FILAMENT PROTEINS; NERVE TISSUE PROTEINS; NEURAL STEM CELLS; OLIGODENDROGLIA; OXIDATIVE STRESS; OXYGEN; PRIMARY CELL CULTURE; RATS; RATS, SPRAGUE-DAWLEY; STEM CELL TRANSPLANTATION; TUBULIN;

MLCS; MLOWN;

EID: 84879721904     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2012-0144     Document Type: Article

References (43)

1. Smith HK, Gavins FN. The potential of stem cell therapy for stroke: IsPISCES the sign? FASEB J 2012;26:2239-2252.
2. Martino G, Franklin RJM, Baron Van Ever-cooren A et al. Stem cell transplantation in multiple sclerosis: Current status and future prospects. Nat Rev Neurol 2010;6:247-255.
3. Cova L, Ratti A, Volta M et al. Stem cell therapy for neurodegenerative diseases: The issue of transdifferentiation. Stem Cells Dev 2004;13:121-131.
4. Brundin P, Barker RA, Parmar M. Neural grafting in Parkinson's disease: Problems and possibilities. Prog Brain Res 2010;184:265-294.
5. Brundin P, Karlsson J, Emgard M et al. Improving the survival of grafted dopaminergic neurons: A review over current approaches. Cell Transplant 2000;9:179-195.
6. Zawada WM, Zastrow DJ, Clarkson ED et al. Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats. Brain Res 1998;786:96-103.
7. Barker RA, Dunnett SB, Faissner A et al. The time course of loss of dopaminergic neurons and the gliotic reaction surrounding grafts of embryonic mesencephalon to the striatum. Exp Neurol 1996;141:79-93.
8. Schierle GS, Karlsson J, Brundin P. MK-801 does not enhance dopaminergic cell survival in embryonic nigral grafts. Neuroreport 1998;9: 1313-1316.
9. Leroux L, Descamps B, Tojais NF et al. Hyp-oxia preconditioned mesenchymal stem cells improve vascular and skeletal muscle fiber regeneration after ischemia through a Wnt4-dependent pathway. Mol Ther 2010;18:1545-1552.
10. Theus MH, Wei L, Cui L et al. In vitro hy-poxic preconditioning of embryonic stem cells as a strategy of promoting cell survival and functional benefits after transplantation into the isch-emic rat brain. Exp Neurol 2008;210:656-670.
11. Oh JS, Ha Y, An SS et al. Hypoxia-precon-ditioned adipose tissue-derived mesenchymal stem cell increase the survival and gene expression of engineered neural stem cells in a spinal cord injury model. Neurosci Lett 2010; 472:215-219.
12. Li TS, Cheng K, Malliaras K et al. Expansion of human cardiac stem cells in physiological oxygen improves cell production efficiency and potency for myocardial repair. Cardiovasc Res 2011;89:157-165.
13. Rosova I, Dao M, Capoccia B et al. Hy-poxic preconditioning results in increased mo-tility and improved therapeutic potentialofhu-man mesenchymal stem cells. Stem Cells 2008; 26:2173-2182.
14. Hu X, Yu SP, Fraser JL et al. Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. J Thorac Cardiovasc Surg 2008; 135:799-808.
15. Silver I, Erecinska M. Oxygen and ion concentrations in normoxic and hypoxic brain cells. Adv Exp Med Biol 1998;454:7-16.
16. Stacpoole SR, Bilican B, Webber DJ et al. Derivation of neural precursor cells from human ES cells at 3% O(2) is efficient, enhances survival and presents no barrier to regional specification and functional differentiation. Cell Death Differ 2011;18:1016-1023.
17. Studer L, Csete M, Lee S Het-aletal/et-al. Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in lowered oxygen. J Neurosci 2000;20:7377-7383.
18. Morrison SJ, Csete M, Groves AK et al. Culture in reduced levels of oxygen promotes clonogenic sympathoadrenal differentiation by isolated neural crest stem cells. J Neurosci 2000;20:7370-7376.
19. Csete M. Oxygen in the cultivation of stem cells. Ann NY Acad Sci 2005;1049:1-8.
20. Chen HL, Pistollato F, Hoeppner DJ et al. Oxygen tension regulates survival and fate of mouse central nervous system precursors at multiple levels. Stem Cells 2007;25: 2291-2301.
21. Pistollato F, Chen HL, Schwartz PH et al. Oxygen tension controls the expansion of human CNS precursors and the generation of as-trocytes and oligodendrocytes. Mol Cell Neu-rosci 2007;35:424-435.
22. Akundi RS, Rivkees SA. Hypoxia alters cell cycle regulatory protein expression and induces premature maturation of oligodendro-cyte precursor cells. PLoS One 2009;4:e4739.
23. Yoshida Y, Takahashi K, Okita K et al. Hyp-oxia enhances the generation of induced pluri-potent stem cells. Cell Stem Cell 2009;5:237-241.
24. Li TS, Marban E. Physiological levels of reactive oxygen species are required to maintain genomic stability in stem cells. Stem Cells 2010;28:1178-1185.
25. Santilli G, Lamorte G, Carlessi L et al. Mild hypoxia enhances proliferation and multipo-tency of human neural stem cells. PLoS One 2010;5:e8575.
26. Cimadamore F, Curchoe CL, Alderson N et al. Nicotinamide rescues human embryonic stem cell-derived neuroectoderm from partha-natic cell death. Stem Cells 2009;27:1772-1781.
27. Clarke L, van der Kooy D. Low oxygen enhances primitive and definitive neural stem cell colony formation by inhibiting distinct cell death pathways. Stem Cells 2009;27:1879-1886.
28. Sakata H, Niizuma K, Yoshioka H et al. Mi-nocycline-preconditioned neural stem cells enhance neuroprotection after ischemic stroke in rats. J Neurosci 2012;32:3462-3473.
29. Adam AA, Takahashi Y, Katagiri S et al. Effects of oxygen tension in the gas atmosphere during in vitro maturation, in vitro fertilization and in vitro culture on the efficiency of in vitro production of mouse embryos. Jpn J Vet Res 2004;52:77-84.
30. Meintjes M, Chantilis SJ, Douglas JD et al. A controlled randomized trial evaluating the effect of lowered incubator oxygen tension on live births in a predominantly blastocyst transfer program. Hum Reprod 2009;24:300-307.
31. Bontekoe S, Mantikou E, van Wely M et al. Low oxygen concentrations for embryo culture in assisted reproductive technologies. Co-chrane Database Syst Rev 2012;7:CD008950.
32. Hack MA, Sugimori M, Lundberg C et al. Regionalization and fate specificationin neuro-spheres: The role of Olig2 and Pax6. Mol Cell Neurosci 2004;25:664-678.
33. Lendahl U, Zimmerman LB, McKay RD. CNS stem cells express a new class of intermediate filament protein. Cell 1990;60:585-595.
34. Eliasson C, Sahlgren C, Berthold CH et al. Intermediate filament protein partnership in astrocytes. J Biol Chem 1999;274:23996-24006.
35. Cimarosti H, Henley JM. Investigating the mechanisms underlying neuronal death in ischemia usinginvitro oxygen-glucose deprivation: Potential involvement of protein SUMO-ylation. Neuroscientist 2008;14:626-636.
36. Goldberg MP, Choi DW. Combined oxygen and glucose deprivation in cortical cell culture: Calcium-dependent and calcium-independent mechanisms of neuronal injury. J Neurosci 1993;13:3510-3524.
37. Mei JM, Chi WM, Trump BF et al. Involvement of nitric oxide in the deregulation of cy-tosolic calcium in cerebellar neurons during combined glucose-oxygen deprivation. Mol Chem Neuropathol 1996;27:155-166.
38. Bell KF, Al-Mubarak B, Fowler JH et al. Mild oxidative stress activates Nrf2 in astro-cytes, which contributes to neuroprotective ischemic preconditioning. Proc Natl Acad Sci USA 2011;108:E1-E2.
39. Davies KJ. The broad spectrum of re-sponsestooxidantsinproliferating cells:Anew paradigm for oxidative stress. IUBMB Life 1999;48:41-47.
40. Oliver PL, Finelli MJ, Edwards B et al. Oxr1 is essential for protection against oxida-tive stress-induced neurodegeneration. PLoS Genet 2011;7:e1002338.
41. Behl C, Moosmann B. Oxidative nerve cell death in Alzheimer's disease and stroke: Antioxidants as neuroprotective compounds. Biol Chem 2002;383:521-536.
42. Trotti D, Danbolt NC, Volterra A. Gluta-mate transporters are oxidant-vulnerable: A molecular link between oxidative and excito-toxic neurodegeneration? Trends Pharmacol Sci 1998;19:328-334.
43. Stacpoole SR, Bilican B, Webber DJ et al. Efficient derivation of NPCs, spinal motor neurons and midbrain dopaminergic neurons from hESCs at 3% oxygen. Nat Protoc 2011;6:1229-1240.